| Q90159160 | A Simple and Effective Sample Preparation Strategy for MALDI-MS Imaging of Neuropeptide Changes in the Crustacean Brain Due to Hypoxia and Hypercapnia Stress |
| Q36683029 | A new murine model of stress-induced complex atherosclerotic lesions |
| Q46267019 | Alpha-adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training |
| Q46792558 | Alpha-adrenergic inhibition increases collateral circuit conductance in rats following acute occlusion of the femoral artery |
| Q37337722 | An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer |
| Q36731621 | Analysis of microarray experiments of gene expression profiling. |
| Q34677131 | Angiogenesis modulates adipogenesis and obesity |
| Q48197251 | Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects. |
| Q37888004 | Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. |
| Q27023800 | Cellular targets for neuropeptide Y-mediated control of adult neurogenesis |
| Q34015479 | Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome |
| Q43425376 | Collateral vessel growth induced by femoral artery ligature is impaired by denervation |
| Q35144928 | Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy |
| Q34288422 | Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia |
| Q36042713 | Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases |
| Q33310598 | Endothelial alpha1-adrenoceptors regulate neo-angiogenesis |
| Q33911425 | Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve |
| Q24803501 | Expression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors |
| Q37806683 | Expression of trophic peptides and their receptors in chromaffin cells and pheochromocytoma. |
| Q45129848 | Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats. |
| Q35740170 | High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases |
| Q37589156 | Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects. |
| Q39036069 | In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis |
| Q34072897 | Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth |
| Q35654597 | Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients |
| Q36117449 | Maternal low-protein diet up-regulates the neuropeptide Y system in visceral fat and leads to abdominal obesity and glucose intolerance in a sex- and time-specific manner |
| Q33676935 | Meta-analysis of low density lipoprotein receptor (LDLR) rs2228671 polymorphism and coronary heart disease |
| Q38572391 | Metastasis: Other Side of the Coin |
| Q37583062 | Microarray analysis for genes associated with angiogenesis in diabetic OLETF keratocytes |
| Q37472507 | Myocardial capillary density after neuropeptide Y antagonist administration in normal and high-fat diet C57BL6 mice. |
| Q36382828 | NPY and stress 30 years later: the peripheral view |
| Q46392911 | Netrin-1 pretreatment protects rat kidney against ischemia/reperfusion injury via suppression of oxidative stress and neuropeptide Y expression |
| Q36586203 | Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology |
| Q24648453 | Neuropeptide Y Y2 receptor in health and disease |
| Q34644169 | Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome |
| Q34200348 | Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy |
| Q51821037 | Neuropeptide Y and its receptors in ventricular endocardial endothelial cells. |
| Q39288801 | Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma |
| Q46635661 | Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats. |
| Q48130652 | Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia |
| Q48496961 | Neuropeptide Y in the brain of Euphlyctis cyanophlyctis tadpoles responds to hypoxic stress |
| Q37794551 | Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition |
| Q35097218 | Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance. |
| Q90024712 | Neuropeptide Y receptor interactions regulate its mitogenic activity |
| Q34970217 | Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients: effect of inflammatory cytokines |
| Q46709448 | Neuropeptide Y stimulates retinal neural cell proliferation--involvement of nitric oxide |
| Q36311441 | Neuropeptide Y3-36 incorporated into PVAX nanoparticle improves functional blood flow in a murine model of hind limb ischemia |
| Q38272415 | Novel roles of perivascular nerves on neovascularization |
| Q51480554 | Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability. |
| Q35045770 | Paracrine control of vascularization and neurogenesis by neurotrophins |
| Q37785576 | Pathophysiology of oral cancer in experimental animal models: a review with focus on the role of sympathetic nerves |
| Q58698726 | Platelet Lysate-Derived Neuropeptide y Influences Migration and Angiogenesis of Human Adipose Tissue-Derived Stromal Cells |
| Q36860246 | Platelet neuropeptide Y is critical for ischemic revascularization in mice |
| Q85843454 | Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy |
| Q89873187 | Role of the nervous system in cancer metastasis |
| Q39914415 | Role of the nervous system in cancer metastasis. |
| Q35792666 | Stress, NPY and vascular remodeling: Implications for stress-related diseases |
| Q33870774 | Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression |
| Q38611988 | Sympathetic nerves: How do they affect angiogenesis, particularly during wound healing of soft tissues? |
| Q35118454 | Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival. |
| Q41903030 | Tbx18 regulates development of the epicardium and coronary vessels. |
| Q89733084 | Temporal Study of the Perturbation of Crustacean Neuropeptides Due to Severe Hypoxia Using 4-Plex Reductive Dimethylation |
| Q57073005 | The Role of Neuropeptide Y in Cardiovascular Health and Disease |
| Q46234408 | The effect of semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of experimental cerebral ischemia |
| Q45925337 | The effects of neuropeptide Y on skeletal muscle contractile properties in streptozotocin diabetic rats. |
| Q38121545 | The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence |